{
  "name" : "dacemirror.sci-hub.se_journal-article_9aa06efae7d2adc7fa8fbe63c4a5a02d_rasmussen2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Review of Achievements of the OECD Working Party on Manufactured Nanomaterials' Testing and Assessment Programme. From Exploratory Testing to Test Guidelines",
    "authors" : [ "Kirsten Rasmussen", "Mar González", "Peter Kearns", "Juan Riego Sintes", "François Rossi", "Phil Sayre" ],
    "emails" : [ "(phil.sayre@verizon.net)", "kirsten.rasmussen@ec.europa.eu," ],
    "sections" : [ {
      "heading" : null,
      "text" : "Accepted Manuscript\nReview of Achievements of the OECD Working Party on Manufactured Nanomaterials' Testing and Assessment Programme. From Exploratory Testing to Test Guidelines Kirsten Rasmussen, Mar González, Peter Kearns, Juan Riego Sintes, François Rossi, Phil Sayre PII: S0273-2300(15)30119-7 DOI: 10.1016/j.yrtph.2015.11.004 Reference: YRTPH 3449\nTo appear in: Regulatory Toxicology and Pharmacology\nReceived Date: 28 May 2015 Revised Date: 8 November 2015 Accepted Date: 10 November 2015\nPlease cite this article as: Rasmussen, K., González, M., Kearns, P., Sintes, J.R., Rossi, F., Sayre, P., Review of Achievements of the OECD Working Party on Manufactured Nanomaterials' Testing and Assessment Programme. From Exploratory Testing to Test Guidelines, Regulatory Toxicology and Pharmacology (2015), doi: 10.1016/j.yrtph.2015.11.004.\nThis is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nReview of Achievements of the OECD Working Party on Manufactured 1\nNanomaterials' Testing and Assessment Programme. 2\nFrom Exploratory Testing to Test Guidelines 3\n4\n5\nKirsten Rasmussen#*, Mar González&, Peter Kearns&, Juan Riego Sintes#, François Rossi#, and Phil 6 Sayre$ 7\n# European Commission, Joint Research Centre, Institute for Health and Consumer Protection, via E. Fermi 2749, 21027 Ispra (VA), Italy 8\n& Organisation for Economic Co-operation and Development (OECD), Environment Directorate, 75775 Paris CEDEX 16, France 9\n$ U.S. Environmental Protection Agency, formerly with Office of Pollution Prevention and Toxics, Washington DC 20460, USA 10 (phil.sayre@verizon.net) 11\n* Corresponding author, e-mail: kirsten.rasmussen@ec.europa.eu, phone: +39 0332 78 5344, fax: +39 0332 78 5388 12\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n13\nAbstract 14\nThis paper charts the almost ten years of history of OECD’s work on nanosafety, during which the 15 programme of the OECD on the Testing and Assessment of Manufactured Nanomaterials covered 16 the testing of eleven nanomaterials for about 59 end-points addressing physical-chemical properties, 17 mammalian and environmental toxicity, environmental fate and material safety. An overview of the 18 materials tested, the test methods applied and the discussions regarding the applicability of the 19 OECD test guidelines, which are recognised methods for regulatory testing of chemicals, are given. 20 The results indicate that many existing OECD test guidelines are suitable for nanomaterials and 21 consequently, hazard data collected using such guidelines will fall under OECD’s system of Mutual 22 Acceptance of Data (MAD) which is a legally binding instrument to facilitate the international 23 acceptance of information for the regulatory safety assessment of chemicals. At the same time, 24 some OECD test guidelines and guidance documents need to be adapted to address nanomaterials 25 while new test guidelines and guidance documents may be needed to address endpoints that are 26 more relevant to nanomaterials. This paper presents examples of areas where test guidelines or 27 guidance for nanomaterials are under development. 28\nKeywords: manufactured nanomaterials, OECD WPMN Testing Programme, OECD test guidelines, 29 Working Party on Manufactured Nanomaterials, regulatory testing 30\n31\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nAbbreviations: AAS: Atomic absorption spectroscopy, AFFFF: Asymmetric flow field flow 32 fractionation, AFM: Atomic force microscopy, BET: Brunauer-Emmett-Teller, BJH: Barrett-Joyner-33 Halenda method, CLS: Centrifugal liquid sedimentation, CNT: Carbon nanotube, Cyto B: Cytochalasin 34 B, DCFH-DA: Dichloro-dihydro-fluorescein diacetate assay, DI: De-ionised (water), DLS: Dynamic 35 Light Scattering, DOSY NMR: Diffusion ordered spectroscopy nuclear magnetic resonance, DSC: 36 Differential scanning calorimetry, DTA: Differential thermal analysis, EDX: Energy dispersive X-ray, 37 ELS: Electrophoretic light scattering, EPR: Electron paramagnetic resonance, GD: Guidance 38 document, HREM: High resolution electron microscopy, HDD: Hydrodynamic diameter, ICP: 39 Inductively coupled plasma, JRC: European Commission's Joint Research Centre, LAL: Limulus 40 amebocyte lysate assay, LDH: , Lit.: Data from literature, MAD: Mutual Acceptance of Data, MWCNT: 41 Multi-walled carbon nanotube, n/a: not applicable, NM: nanomaterial, OECD: Organization for 42 Economic Co-operation and Development, ORP: Oxidation, reduction potential, POM: Polarizing 43 optical microscopy, RBA: Rose bengal adsorption method, ROS: Reactive oxygen species, SAXS: Small 44 angle X-ray scattering, SDR: SensorDish reader, SEM: Scanning electron microscopy, SMPS: Scanning 45 mobility particle sizer™ (SMPS™) spectrometer analysis, SWCNT: Single-walled carbon nanotube, 46 TEM: Transmission electron microscopy, TG: Test guideline, TGA: Thermo-gravimetric analysis, TGP: 47 Test Guidelines Programme, ToF-SIMS: Time-of-flight secondary ion mass spectrometry, USAXS: 48 Ultra small angle X-ray scattering, UV-vis: Ultra violet-visible, WPMN: Working Party on 49 Manufactured Nanomaterials, WNT: Working group of the national co-ordinators for the OECD test 50 guidelines programme, XDC: X-ray disc centrifuge, XPS: X-ray photoelectron spectroscopy, XRD: X-51 ray diffraction, XRF: X-ray fluorescence, XTT: 2,3-bis[2-Methoxy-4-nitro-5-sulfophenyl]- 2H-52 tetrazolium-5-carboxyanilide 53\n54\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n1. Context and Background 55\nIn the past 15 years, significant efforts have been directed towards understanding nanomaterials 56 regarding properties, applications and safety aspects, as well as identifying any specific needs for 57 regulation. These issues and progress in addressing them have been monitored by policy makers 58 (SCENIHR 2006, SCENIHR 2007a, SCENIHR 2007b, SCENIHR 2009, European Commission, 2012) and 59 also supported by for example the USA National Nanotechnology Initiative at 60 http://www.nano.gov/you/environmental-health-safety1. 61\nIn 2006 the OECD Working Party on Manufactured Nanomaterials was established to provide a 62 global forum for nano-safety discussion, also in a regulatory context. It is a subsidiary body of the 63 OECD Chemicals Committee with more than 40 years' experience leading a global programme 64 promoting the understanding of environment, health and safety aspects of chemicals (see links 65 http://www.oecd.org/chemicalsafety/ and http://www.oecd.org/environment/40yearschemicals). 66 Box 1 gives an overview of the areas of work addressed by the WPMN (see link 67 http://www.oecd.org/science/nanosafety/). 68\nIn 2011 Morris et al. (Morris et al. 2011) identified the OECD as one of the key bodies to address 69 nanotechnology governance issues, achieved mainly through the WPMN, but other groups also 70 contribute such as the OECD National Co-ordinators of the Test Guidelines Programme (see link 71 http://www.oecd.org/env/testguidelines). 72\nBox 1. Areas of work within the WPMN. 73\na) Testing and Assessment. 74 This has included the testing of selected nanomaterials for physical-chemical properties, and human 75 health and environmental safety endpoints, using appropriate testing methods to generate data and 76 assess the need for the development of new test guidelines, the updating of existing guidelines, or 77 supplementary guidance that will allow the use of existing or new guidelines. The aim is to ensure 78\n1 All links to URLs in the text were accessed 28 May 2015\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nthat adequate means are available to identify possible hazards posed by nanomaterials, while 79 promoting the development of alternative test methods for nano-toxicity testing. 80\nb) Promoting international co-operation on Risk Assessment and Regulatory Programmes. 81\nc) Identifying and developing guidance on Exposure Measurement and Exposure. 82\nd) Promoting the Environmentally Sustainable Use of Nanotechnology. 83 84\nThe OECD agreement of Mutual Acceptance of Data in the Assessment of Chemicals (OECD 1981) 85 (see link http://www.oecd.org/env/ehs/mutualacceptanceofdatamad.htm), is an essential 86 component for international harmonisation of approaches to chemical safety through regulatory 87 recognition of these test guidelines. One corollary of MAD is recognition of tests performed 88 according to OECD test guidelines, which are test methods for regulatory testing of chemicals, in 89 countries adhering to MAD. Accordingly, an important task under the WPMN is to ensure that OECD 90 test guidelines are applicable to nanomaterials, thus falling under MAD. OECD test guidelines are 91 developed in the OECD test guidelines programme, and agreed TGs are published by the OECD at the 92 link http://www.oecd.org/chemicalsafety/testing/oecdguidelinesforthetestingofchemicals.htm . 93 Guidance documents on testing do not fall under MAD but nevertheless reflect an agreement on 94 best available procedures. 95\nThe OECD test guidelines programme ensures the development and relevant updating of TGs for the 96 regulatory hazard testing of chemicals through a consensus process in the OECD WNT, building on 97 knowledge from research and as well as regulatory requisites, such as relevance and reproducibility. 98 The OECD test guidelines are developed for chemicals in general and are thus broadly applicable, but 99 the individual test guidelines may not be applicable to all chemicals. Usually, recognised limitations 100 in the area of application is stated in the test guidelines. 101\nIn parallel with the work in the OECD WPMN, research projects, for example projects under the 102 European Union's 7th Framework programme, have contributed research results to the 103\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nunderstanding of testing of nanomaterials and their properties, providing additional insights that 104 also contribute knowledge to develop OECD guidance for the testing of nanomaterials. 105\nThis paper provides an overview of the activities and initial outcomes of the OECD work on the 106 Testing and Assessment of Manufactured Nanomaterials, which was formally completed in 2013, 107 and it especially focussed on understanding the adequacy of the applied test guidelines. In the 108 following, the terms Manufactured Nanomaterials and Nanomaterials are used interchangeably. 109\n110\n2. The WPMN Testing and Assessment Programme 111\nThe aim of the WPMN Testing and Assessment Programme was to generate datasets for an agreed 112 list of nanomaterials, and via subsequent analysis of the methods applied, to obtain information 113 contributing to nanomaterial-relevant updates of OECD test guidelines and/or guidance documents 114 for testing and risk assessment. Each material was tested by a group of so-called sponsors, who 115 decided on the test methods to apply to their material. To help and guide the sponsors, a guidance 116 manual for the testing of manufactured nanomaterials for OECD’s Sponsorship programme was 117 developed (OECD 2009a). The outcomes of the Testing and Assessment Programme includes 118 exploratory testing of eleven nanomaterials, as indicated in Table 1, for about 59 end-points 119 concerning physical-chemical properties, mammalian and environmental toxicity, environmental 120 fate and material safety, as indicated in Table 2. In addition to the nanoform(s), a non-nano form 121 was tested for TiO2, CeO2 and ZnO. The datasets were of an exploratory nature and without pre-122 defined regulatory consequences. The following sections present the information available by June 123"
    }, {
      "heading" : "2014. 124",
      "text" : "The information on the endpoints was generated using current OECD TGs, sometimes with ad-hoc 125 adaptations, or other methods. Regulatory data generation for traditional chemicals applies testing 126 strategies that can integrate non-animal and animal testing to assess environmental and health 127\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nsafety. There is considerable interest in exploratory research into alternative methods and their 128 potential application as part of an integrated testing strategy for nanomaterials. 129\nTable1. Nanomaterials for which provided data is generated in the WPMN Testing Programme. 130\nChemical Name of Material Name of Principal Nanomaterial(s) tested Name of Alternate Nanomaterial(s) tested C60 Fullerenes Nanom Purple - Single walled carbon nanotubes (SWCNT) Nikkiso SWCNT,\nSuper growth\n-\nMulti walled carbon nanotubes (MWCNT) Nikkiso MWCNT,\nGraphicstrength C100, Nanocyl NC7000\nMitsui MWNT-7 Baytubes Hanwa CM100\nSilver Citrate capped silver nanoparticles. ABC Nanotech Co. Ltd., Korea\nSilver powder. NAMATECH Co. Ltd., Korea Silver powder. Daedeok Science, Korea Silver powder. Sigma-Aldrich, USA\nNM-300K, rent a scientist, GmbH, Germany\nGold NM-330 - Titanium dioxide (TiO2) P 25 (NM-105) NM-101, NM-102, NM103, NM-104 Cerium dioxide (CeO2) NM-211 and NM-212 - Zinc oxide (ZnO) NM-110, NM-111 and NM-112 - Silicon dioxide (SiO2) NM-200 NM-201, NM-202, NM203, NM-204, Korean SiO2 Dendrimers PAMAM dendrimers:\nG3-PAMAM-(NH2)32 and G4-PAMAM--(NH2)64\n-\nNanoclay NM-600 -\n131 132 The six groups of end-points investigated in the Testing and Assessment Programme, as indicated in 133 Table 2, are similar to the end-points for hazard assessment of chemicals, with the exception of 134 physical-chemical data, which are particular to characterising nanomaterials. The information 135 pertaining to Group A is descriptive, and for Group F testing may not be needed as the materials 136 investigated are not likely to be flammable, explosive or reactive; Groups A and F are not further 137 discussed here. 138\nACCEPTED MANUSCRIPT\n141 The same lot and batch of nanomaterial are used for testing of all end-points thus ensuring that 142 physical-chemical data, toxicology data and environmental data can be compared. The Joint 143\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nResearch Centre established the JRC Nanomaterials Repository for Representative Nanomaterials. It 144 provided samples of 8 of the nanomaterials tested in the test programme. 145\nThe Testing Programme was finalised in 2013, and the raw data is becoming publicly available from 146 the OECD since June 2015 at http://www.oecd.org/chemicalsafety/nanosafety/testing-programme-147 manufactured-nanomaterials.htm. The initial process of extracting information from the Testing 148 Programme, collecting the research experiences, analysing the testing outcomes, and evaluating the 149 resulting regulatory needs was carried out through expert meetings on i) Physical-Chemical 150 Properties of Manufactured Nanomaterials and Test Guidelines (2013) (OECD 2014a), ii) 151 Nanomaterials Physical-Chemical Parameters: Measurements and Methods (2014); iii) 152 Environmental Fate & Eco-Toxicology (2013) (OECD 2014b, Kühnel and Nickel, 20114); iv) Inhalation 153 Toxicity Testing for Nanomaterials (2011) (OECD 2012a); v) Genotoxicity of Manufactured 154 Nanomaterials (2013) (OECD 2014c); vi) Toxicokinetics of Nanomaterials (2014) and vii) 155 Categorization of Manufactured Nanomaterials (2014). An expert meeting on Read Across of Data 156 and Categories for Manufactured Nanomaterials is planned for 2016. For ii), vi) and vii) the OECD 157 publication procedure is underway. Each report presents a summary of the meeting including the 158 objectives and the agenda; recommendations including proposals for modification of, or new, OECD 159 Test Guidelines; synopsis of the presentations and the discussions; as well as a list of participants. 160\n161\n3. Sample Preparation and Dispersion Media 162\nAn issue raised consistently when testing nanomaterials, both within the WPMN and in the scientific 163 literature, is the sample (test item) preparation and dispersion in appropriate media. It is recognised 164 that possible hazards associated with nanomaterials may be affected by, for example, shape, size 165 and surface area, because these parameters affect both the mode of action and toxicokinetics of 166 particles (absorption, distribution, and excretion). 167\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nTest item preparation and dispersion (including stability) in appropriate media is a critical issue, 168 since many of the nanomaterials are insoluble or sparingly soluble in water and other media used in 169 (eco)toxicological tests. Moreover, their physical-chemical properties as well as (eco)toxicological 170 effects are highly influenced by the interactions with the bio-physical-chemical surroundings in these 171 media. Thus, sample characterisation should be performed for a number of the different stages of 172 testing nanomaterials. The testing stages may include powder and/or dispersion forms depending 173 on the end-point and/or the stage tested, and the actual material tested (the test item) has 174 undergone a critical process of preparation that needs to be controlled, consistent, relevant, reliable 175 and robust. 176\nThe updated OECD Guidance Document on Sample Preparation and Dosimetry (OECD 2012b) is 177 considered a milestone in the development of guidance for adequately addressing hazard testing of 178 nanomaterials, as indicated for instance in the OECD Council Recommendation (OECD 2013a). This 179 guidance document refers and applies to water insoluble manufactured nanomaterials, as it was 180 considered unlikely that soluble nanomaterials would need a sample preparation different from 181 what is applied to chemicals in general. An extensive effort has been undertaken outside the OECD to 182 classify NMs into different subclasses, see for example: 183 http://www.codata.org/uploads/Uniform_Description_System_Nanomaterials-Published-v01-15-02-01.pdf. 184 Consulting such a classification system to identify which sub-class the nanomaterial about to be tested belongs 185 to, could facilitate the sample preparation and dosing step(s). 186\nIt should be noted that the classical dose metrics used to describe doses (dosimetry), e.g. milligram 187 test substance per kilogram test animal, may not be the most suitable for nanomaterials (SCENIHR 188 2006). Since publication of the Guidance Document on Sample Preparation and Dosimetry a number 189 of protocols have emerged (NIST, link http://www.nist.gov/mml/np-measurement-protocols.cfm, 190 PROSPEcT, link 191 http://www.nanotechia.org/sites/default/files/files/PROSPECT_Dispersion_Protocol.pdf, 192 Nanogenotox, link 193\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nhttp://www.nanogenotox.eu/files/PDF/Deliverables/nanogenotox%20deliverable%203_wp4_%20di194 spersion%20protocol.pdf; and ENPRA (Jacobsen et al. 2010)) and recommendations (Tantra et at. 195 2014) aiming to become reference for future studies. Also the dispersion of nanomaterials for 196 testing has been further studied, and a review of several aqueous dispersion protocols for 197 nanomaterials in aqueous media (Hartmann et al. 2015) analysed which aspects of dispersion 198 procedures could be harmonised. 199\n200\n4. Testing Performed and Test Methods Applied 201\nBelow, the testing performed and the method(s) applied to each nanomaterial and endpoint are 202 described, and this information is presented according to the end-point groups (B to E) in Table 2. 203\n4.1. Tests performed and methods applied to Physical-chemical Properties and Material 204\nCharacterization (Group B) 205\nTable 3 gives an overview of the physical-chemical testing and techniques applied for each end-point 206 and material, as indicated for example in Singh et al. (Singh et al. 2013, Singh et al. 2014) and 207 Rasmussen et al. (Rasmussen et al. 2013). Analysing the information available for the nanomaterial 208 groups, the following preliminary observations and conclusions were made (data analysis is still on-209 going): 210\nSome Observations relevant to nanomaterials investigated 211\n• Four groups of materials were investigated: pure metal (gold and silver), metal oxides (TiO2, 212 SiO2, CeO2 and ZnO), inorganic carbon-based nanomaterials (fullerenes, SWCNTs and 213 MWCNTs) and others (dendrimers and nanoclays). 214\n• Gold and silver are provided in a liquid suspension, and so dustiness and pour density are 215 not relevant. 216\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n• SWCNTs and MWCNTs may have a high aspect ratio and may be entangled, and application 217 of techniques that measure hydrodynamic size did not lead to meaningful size distribution 218 determinations. 219\n• Dynamic Light Scattering was employed, with some success, to measure the hydrodynamic 220 diameter of the metal oxides, but in general, the application of DLS to \"unknown\" materials 221 is not advised (Calzolai et al. 2011). 222\nSome observations regarding the end-points 223\n• Two end-points, octanol-water partition coefficient and solubility in water (and other 224 media), are not applicable to those nanoparticles which are not readily dissolved in the 225 liquids; readily dissolvable nanomaterials would be assessed as traditional chemicals. 226\nSome observations relevant to measurement techniques applied 227\n• For most of the nanomaterials, Transmission Electron Microscopy micrographs were made, 228 and TEM was found to give the best qualitative size and shape description of the materials 229 including evaluation of agglomeration and aggregation. A new method was proposed (de 230 Temmerman et al. 2012) applying quantitative randomized acquisitions and image analysis. 231\n• X-ray diffraction was successfully applied to the metals and metal oxides to investigate 232 crystallinity. 233\n• Raman spectroscopy was successfully applied to SWCNTs and MWCNTs to investigate 234 crystallinity. 235\n• The standard technique for specific surface area measurement is BET adsorption. In the 236 WPMN testing programme it was applied to 8 of the nanomaterials. 237\n• Dustiness was assessed by two methods: the vortex shaker method and a modified CEN 238 standard EN 15051; these methods gave different, and not correlated, results. 239\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n• The Zeta potential is not directly measurable and was calculated using Henry’s equation 240 applied to the results from by various electrophoresis measurements. 241\n• UV-vis analysis may be used to measure size of pure metals in a liquid suspension (Ag and 242 Au). 243\nCrystallinity was investigated by XRD (metals and metal oxides) and Raman spectroscopy (CNTs) 244 and the choice of technique reflect the organisation of the testing, which was in different 245 laboratories with different apparatus available. 246\nTable 3. Group B. Physical-chemical Properties and Material Characterization and associated 247 measurement techniques* used for testing the Nanomaterials based on information in the 248 dossiers. 249\nPhysical-chemical Properties and Material Characterization\nMethods* used in the Testing Programme\nApplied to nanomaterial\nC 60\nS W\nC N\nT\nM W\nC N\nT\nA g\nA u\nT iO\n2\nC eO\n21 3\nZ n\nO 1\n2\nS iO\n21 4\nD en\nd ri\nm er\ns\nN an\no cl\nay\n10. Agglomeration / aggregation\nSAXS / USAXS x x DLS x x x x x x x TEM x x x x x x x x SEM x x x x x UV-vis x x DOSY NMR x CLS x x x x Turbidity x x x Other ISO 9276-2 Read-across from literature or n/a x x n/a x ELS x x\n11. Water solubility OECD 105 x x\nTurbidity x x x Flask method x SDR x x\n12. Crystalline phase\nXRD x x x x x x x Raman x x TEM x x x Other DSC, POM\nn/a n/a n/a\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nPhysical-chemical Properties and Material Characterization\nMethods* used in the Testing Programme\nApplied to nanomaterial\nC 60\nS W\nC N\nT\nM W\nC N\nT\nA g\nA u\nT iO\n2\nC eO\n21 3\nZ n\nO 1\n2\nS iO\n21 4\nD en\nd ri\nm er\ns\nN an\no cl\nay\n13. Dustiness EN 15051 x x\nModified EN 15051 x x Vortex shaker method x x x x x\n14. Crystallite size\nn/a\nXRD x x x x x SAXS / USAXS x x TEM x x x x OECD TG 110 x UV-vis x DLS x\n15. Representative TEM picture(s)\nTEM x x x x x x x x x x HREM x\n16. Particle size distribution\nDLS x x x x x x x x x SEM x x x x x TEM x x x x x x AFM x x DOSY NMR x ISO 10808 x SMPS x x x x CLS x x x x x\n17. Specific surface area\nBET ISO 9277, 2010\nx\nx\nx\nx\nx\nx x x x\nSAXS x x\n(VSSA) TEM tomography x\n18. Zeta potential (surface charge)\nElectrophoretic mobility method\nx x x\nELS x Zetasizer DLS x x x Ultrasonic spectroscopy x Doppler microelectrophoresis x x x\n19. Surface chemistry (where appropriate)\nn/a n/a\nICP-OES x SEM EDX x XPS x x x x x Other EDS, RBA ToFSIMS DTA, TGA\nEDX\n20. Photo-catalytic activity\nn/a\nISO 22197-1 / JIS R 170-1 x x x UV-vis x x x\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nPhysical-chemical Properties and Material Characterization\nMethods* used in the Testing Programme\nApplied to nanomaterial\nC 60\nS W\nC N\nT\nM W\nC N\nT\nA g\nA u\nT iO\n2\nC eO\n21 3\nZ n\nO 1\n2\nS iO\n21 4\nD en\nd ri\nm er\ns\nN an\no cl\nay\nEPR x KI test x x\n21. Pour density\nn/a n/a n/a\nJIS K 6219-2, 2006 x ASTM D 1513-05 x x BET x Tapped density x x Weighing x\n22. Porosity\nn/a Lit.\nBHJ x x BET x x x x ISO 15901-1 x x x\n23. Octanol-water partition coefficient, where relevant\nLit. n/a n/a n/a n/a n/a n/a Lit.\nOther Flask Meth.\nTG 107, TG 117\n24. Redox potential\nSDR x x ORP, Cyclic voltametry x x\n25. Radical formation\nLit. n/a\nEPR x UV-vis and KI test x x\n26. Other TGA\n*METHODS: please note that the methods appear under \"abbreviations\". x: this test was performed with indicated method 250 251 4.2 Tests performed and methods applied to Groups C Environmental Fate and D 252\nEnvironmental Toxicology 253\nTable 4 and 5 give an overview of the testing performed for environmental fate and environmental 254 toxicology. 255\nThe nanomaterials tested are mainly metals and metal oxides for which classical biotic degradability 256 testing (developed for organic chemicals) is not relevant. Biotic degradability testing was performed 257 with SWCNTs and MWCNTs, which are inorganic carbon-based nanomaterials, and the conclusion 258\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nwas that the materials are not biodegradable. Testing of degradation products was thus not 259 performed. 260\nAnalysis of the data (OECD 2014b; Kühnel and Nickel 2014) showed that the environmental targets 261 tested for traditional chemicals were applicable to nanomaterials, as were the endpoints examined 262 for each organism or fate protocol. One exception to this conclusion, given the current state of 263 knowledge on nanomaterial fate and effects, is that more work may be needed in the area of 264 nanomaterial biokinetics due to differences in nanomaterial uptake and distribution compared to 265 traditional chemicals. 266\nSome important principles identified were: 267\n* the need for characterization of the physical-chemical properties of nanomaterials (OECD 2012b). 268\n* due to differences in nanomaterial fate and exposures compared with traditional chemicals, a fate 269 decision tree logic and testing strategy on dissolution rate, agglomeration behaviour, and fate 270 testing are needed covering water, soil and sediment and establishing a tiered scheme to target 271 appropriate fate and ecotoxicity tests. 272\n* the same method for preparing stock suspensions should be applied to all tests allowing an easier 273 comparison of data when performing ecotoxicity and bioaccumulation tests. 274\n* the best spiking (wet or dry) procedure for ecotoxicity testing of nanomaterials is still not clear. 275\n* to promote the comparability of results of ecotoxicity and fate tests, the same test conditions 276 should be used, e.g. parameters of the suspension and test media. 277\n* since the most appropriate dose metrics may not be known for environmental receptors and/or 278 anchoring to mass-based dose metrics is still needed, the ability to interconvert doses from mass to 279 particle counts to surface area is essential (OECD 2012b). 280\nIn addition to the cross-cutting conclusions above, the application of certain individual 281 environmental toxicity and fate OECD test guidelines should be supported by additional guidance, 282\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nand other OECD test guidelines were considered inappropriate for nanomaterials. Section 6 283 addresses both agreed and proposed changes to the test guidelines and guidance documents for 284 nanomaterials. 285\nSpecific research needs were also identified: for aquatic ecotoxicity, there is a need to determine 286 possible interferences with nanomaterials and test assay components, effects of pristine versus 287 altered nanomaterials; for soils and sediments, better understanding of the bioavailable fractions of 288 nanomaterials, spiking techniques, and the applicability of TGs to novel environmental receptors is 289 needed; and for environmental fate and behaviour, dispersion/dissolution/ transformation in 290 environmental media, and use of different soil types need further investigation. 291\nACCEPTED MANUSCRIPT\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nNanomaterials\nEndpoints\nFullerenes C60\nSWCNTs MWCNTs Silver Gold TiO2 CeO2 ZnO SiO2 Dendrimers\nBioaccumulation in sedimentdwelling Benthic Oligochaetes\n- Read across\nfrom literature data\n- - - - - - - -\nOther relevant information\nRead across from lit.: Temporal changes in\naqu/C60 physchem, deposition and trans- port characteristics in aquatic systems\n- -\nStability in seven soils. Speciation of\nsilver in antimicrobial fabric before and after expo-sure to a hypochlorite\ndetergent solution\nyes yes\nTracing of isotopes. Comparison of natural isotopes and studied material's isotopes for\nidentification of Cerium/ in the environment\nTracing of isotopes. Comparison of natural isotopes and studied material's isotopes for identification of Zinc/ in\nthe environment\n- -\nTable 5. Overview of methods applied for the tests performed for Environmental toxicology end-points (Nanoclays are not listed as No data was provided by June 2014)\nNanomaterials\nEndpoints\nFullerenes C60\nSWCNTs MWCNTs Silver Gold TiO2 CeO2 ZnO SiO2 Dendrimers\nPelagic species\nFish\n• OECD 203,\nand read across from\nliterature\n• OECD 203,\nOECD 204 and literature data\n• OECD 203, OECD 204\n• OECD 203, OECD 210, OECD 212, fish embryo toxicity test, DIN 384 15\nT6\n• OECD 203,OECD draft TG (fish test\nwith embryos)\n• OECD 212, OECD 236\n• OECD 212\n- •\nOECD 203 (performed in\n1991)\nLiterature data: Zebra fish embryo toxicity tests\nCrustaceans - •\nOECD 202, OECD 211, and literature data\n• OECD 202, OECD 211\n• OECD 202\n• OECD 202\n• OECD 202, ISO\n10872, OECD 211, EPSI/11RM/33, OECD\n219, OECD 225\n• OECD 202, OECD\n211\n• OECD 202\n• OECD 202\n(performed in 1991)\nLiterature data (1) using British standard 1996 with Daphnia magna; and (2) test with Thamnocephalus platyurus\nAlgae - •\nOECD 201\n• OECD 201, and literature data\n• OECD 201\n• OECD 201\n• OECD 201, EPSI/RM/25\n• other\n- - •\nLiterature data using OECD 201, and Chlamydomonas\nreinhardtii\nSediment species\n- - - • • - - - - -\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nNanomaterials\nEndpoints\nFullerenes C60\nSWCNTs MWCNTs Silver Gold TiO2 CeO2 ZnO SiO2 Dendrimers\nOECD 219 OECD 219\nSoil species - - -\n• OECD 207, OECD 222, other test methods, soil enzyme activity, ASTM\nE2172-01\n- - - - - -\nTerrestrial species\n- • OECD 216\n• OECD 216\n• OECD 207, OECD 208, OECD 216, OECD 217 Plant toxicity Literature data\n• OECD 207\nASTM E2172-01; OECD 208 USEPA\necological effect test. OECD 222, OECD 226, microarray, qRTPCR; repro. test\n- •\nOECD 207, OECD 222\n- -\nMicroorganisms - •\nOECD 209, and literature data • OECD 209, and literature data\n• No OECD TG available so other method used\nand several microorganisms were used.\nDIN 38412-48\n• ISO 11348-\n2:2007\n• OECD 216,\nOECD217, OECD 209\n- - - Literature data with Vibrio fischeri:\nActivated sludge at WWTP\n- • OECD 209\n• OECD 209\n- - - - - - -\nOther relevant information - -\nYes: micro nucleus assay with Xenopus\nlaevi\n• OECD 221\nyes yes - - -\n• Yes: In vitro tests with RTG-\n2 cells from rainbow trout gonodal tissue\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n4.3 Testing performed and applied methods for Group E, Mammalian Toxicology 193\nAn overview of the tests performed for mammalian toxicology end-points is presented in Table 6. 194 For inhalation toxicity testing, the conclusions were to update the OECD test guidelines and the 195 “Preliminary Guidance Notes on Sample Preparation and Dosimetry” for which the update is now 196 published (OECD 2012b). Further recommendations included considerations on how to generate test 197 atmospheres for nanomaterials depending on the use of the toxicity tests. While inhalation toxicity 198 tests with aggregates or agglomerates of nano-sized particles seem adequate for hazard and risk 199 assessment for the handling of powders, it may be relevant for hazard and risk assessment of 200 nanoparticles in the production phase to include inhalation toxicity of aerosols consisting of single 201 nanoparticles. Care should be taken to correct for the fact that at high mass concentrations, size 202 distributions will shift towards larger particles due to agglomeration as a function of time and 203 particle number concentrations. As already noted, the dose metrics needs to be carefully 204 considered. 205\nFor testing genotoxicity of manufactured nanomaterials, seven consensus statements were agreed 206 on and are shown below in box 2. Table 9 lists the OECD test guidelines proposed for updating in this 207 context. 208\nIt was furthermore decided to carry out an interlaboratory testing campaign to evaluate and 209 improve the micronucleus assay in the context of the WNT. 210\n211\nBox 2. Consensus statements from the OECD Expert meeting on genetoxicity testing for manufactured 212 nanomaterials (OECD 2014c) 213\n1. The use of the Ames test (TG 471) is not a recommended test method for the investigation of the genotoxicity of nanomaterials. The test guidelines programme should consider modifying the applicability domain within this test guideline accordingly.\n2. Measures of cytotoxicity based on cell proliferation that are described in the test guidelines are appropriate\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nfor determining the top concentration to be applied for in vitro tests of nanomaterials. It is appropriate in some cases to consider wider concentration spacing than the standard √10 in order to ensure the concentration-response relationship is well characterized, and at concentrations not associated with cytotoxicity.\n3. Characterisation of the materials should be undertaken in the cell culture medium used both at the beginning of treatment and, where methodologies exist, after treatment. The intent when applying nanomaterials to a cell culture medium is to create conditions that are comparable, to the extent possible, with the biological and physiological conditions within the in vivo system.\n4. The extent of cellular uptake is a critical factor to consider when interpreting test results. In some circumstances, a lack of uptake in a mammalian cell may indicate a low intrinsic hazard from a direct genotoxicity perspective.\n5. The test guidelines program should consider modification of the in vitro micronucleus assay to recommend, where cyto B is used, its addition using a post-treatment or delayed co-treatment protocol, in order to ensure a period of exposure of the cell culture system to the nanomaterial in the absence of cyto B.\n6. Prior to conducting an in vivo genotoxicity study, there is a need to conduct some toxicokinetic investigations to determine if the nanomaterial reaches the target tissue, where the target tissue is not the site of contact. In the absence of data to the contrary, the test is not applicable for detecting primary genotoxicity if the nanomaterial does not reach the target tissue.\n7. There are insufficient data to recommend one route of administration over another. The basis for selecting the route of administration for testing should be to consider the route most applicable to human exposure(s).\n214\nACCEPTED MANUSCRIPT\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nNanomaterials\nEndpoints\nFullerenes C60\nSWCNTs MWCNTs Silver Gold TiO2 CeO2 ZnO SiO2\nOECD 407 OECD 407 OECD 407 OECD 407, OECD 408, OECD 422\nOECD 407 admin. intravenous\nOECD 408, other study\nOECD 407 (oral gavage), OECD 408, OECD 412\nDermal - - - - - •\n5-day dermal adsorption\n-\nInhalation •\nother methods\n• OECD 412, and read across from\nliterature (intratracheal\ninstillation study pharyngeal aspiration study)\n• OECD 412, OECD 413,\nOther methods\n• OECD 412, OECD 413\n• OECD-STIS, OECD 412, OECD 413\n• OECD 412, intratracheal\ninstillation, literature review\n• OECD 412\n• 5-day lung toxicity study, OECD 412,\nmodified OECD 413\n• 5-day DRF, OECD\n413\nIf Available\nChronic Toxicity - - •\nSingle intra-peritoneal injection\n- - - - -\nReproductive Toxicity Literature data • OECD 416\n• Screening test - - - • - - - - -\nDevelopmental toxicity - - •\n• - - - - -\nGenetic toxicity\nIn Vitro Genotoxicity\n• OECD 471, OECD 473,\nJapan Guideline for screening Mutagenicity\ntesting of chemicals\n• Literature data for OECD 471, OECD 473 and Comet assay and other • OECD 471, OECD 473, OECD 476,\n• OECD 473\n• OECD 471, OECD 473,\nComet assay,\n• OECD 471, OECD\n473,OECD 476, OECD 487,Comet\nassay, literature data, literature review of photogenotoxicity.\n- •\nOECD 471, OECD 473\n• Comet assay,\nOECD 487, OECD 476, OECD 473,\nIn Vivo Somatic cell Genotoxicity, mammalian bone marrow chromosome aberration test\n• OECD 474, OECD 475\n• OECD 474\n• OECD 474\n• OECD 474\n- • OECD 474,\n- • OECD 474\n• OECD 474, comet\nassay\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nNanomaterials\nEndpoints\nFullerenes C60\nSWCNTs MWCNTs Silver Gold TiO2 CeO2 ZnO SiO2\nIn Vivo Germ cell mutagenicity\n•\nOECD 474, read across from\nliterature\n- •\nOECD 474\n- - - - - •\nOECD 474\nExposure related to humans - - - •\nHealth surveillance\nstudy\n• Lab. exposure surveillance\nstudy\n- Ref. Park et al., 2008\n- -\nOther relevant test data\nIn Vivo tests - yes yes _ no yes\n•\n\"Effects of subacute inhalation of diesel exhaust with CeO2\nin mice\". LDHrelease assay, MTT assay, NRU assay.\nyes yes\nIn Vitro tests Cell lines A459, HaCaT, THP-1 yes yes yes\nCytotoxicity, cellular uptake,\nXTT assay, LDH-release assay, ATPbased assay,\nDCFH-DA assay, LAL test\nCytotoxicity, permeability, XTT\nassay, LDH-release assay, ATP-based assay, DCFH-DA assay, LAL test\nYes. NanoCare in vitro tests, yes yes\n1. Dendrimers were without a lead sponsor and the co-sponsor investigated environmental characteristics, and the mammalian end-points are not addressed. Nanoclays were started late and no toxicology information was available by June 2014. OECD-STIS: OECD short term inhalation study • Completed (At least one test was completed amongst the principal nanomaterials and the participants) - Not addressed / No information yes Relevant information was provided or not.\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n4.4 In vitro testing performed and assays applied 215 In vitro assays were efficient for screening of nanomaterials (Nel et al. 2013), although, because of 216 sedimentation effects (Teeguarden et al. 2007, DeLoid et al. 2014), unless doses are adjusted to account for 217 nanomaterial transport, the dose response relationships cannot easily be used to derive no effect levels. 218\nC60 fullerenes, SWCNTs and MWCNTs were investigated for their potential genotoxic hazard in vitro and in 219 vivo. In addition to the Japanese Guidelines, the in vitro TG 471 (Bacterial Reverse Mutation Test) and TG 473 220 (In Vitro Mammalian Chromosome Aberration Test) were applied to carbonaceous nanoparticles. Also the in 221 vivo TG 474 (Mammalian Erythrocyte Micronucleus Test) and various forms of the Comet assay were 222 performed. 223\nAlthough mutation frequencies and chromosomal aberrations were not detectable in vitro using TG 471 224 (please note the recommendations in Box 2) and TG 473, respectively, there are some indications of DNA 225 damage on lung hamster fibroblasts (V79) when using the Comet assay with some types of SWCNT and 226 MWCNT. Interestingly, the DNA damaging properties of a few CNT were confirmed in vivo on target tissue 227 cells. 228\nUsing the In Vitro Mammalian Cell Gene Mutation Test (TG 476) two MWCNT investigated did not 229 demonstrate mutagenic activity in L5178Y mouse lymphoma cells, although one MWCNT showed significant 230 numerical chromosomal aberrations (TG 473) and induced micronucleus formation in CHL/IU cells (In Vitro 231 Mammalian Cell Micronucleus Test; TG 487). 232\nThese results confirmed that for risk assessment, a case-by-case investigation of the genotoxic hazard both 233 for a chemical entity and for each type of nano-object (such as particles, fibres, rods and clusters) is needed. 234\nThe combined in vitro and in vivo results and the scientific knowledge of physical-chemical behavior 235 nanomaterials led to a proposal for an integrated testing strategy, currently under development. 236\n237\n5. Amendments to the OECD Test Guidelines and Guidance Documents for Nanomaterials 238\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nAn important issue when integrating testing of nanomaterials in the OECD test guidelines is to ensure that 239 the test guidelines are as broadly applicable as possible. For the development of the OECD TGs the WNT 240 identify and nominate experts from within the relevant field as well as experts in regulatory toxicology. 241 Many nanomaterials are poorly soluble or completely insoluble in aqueous media and have limited 242 degradability, to address this, the before mentioned Guidance on Sample Preparation and Dosimetry (OECD 243 2012b) was published. Furthermore, it leads to new considerations of physical-chemical characterization 244 protocols, e.g. how to determine the most biologically relevant particle size distributions and surface area 245 measurements; fate protocols on how to disperse materials realistically for testing; aquatic testing protocols 246 where the possible lack of stability of the suspension leads to concern regarding stability of test 247 concentrations and associated dose metrics; and inhalation tests where nanomaterials may agglomerate in 248 aerosols and/or prompt the need for lung burden analyses, examination of nanomaterials surface-in vivo 249 fluids interactions, etc. Regarding environmental fate and toxicity testing, selected TGs were discussed and it 250 was found that OECD TGs 201 (algal and cyanobacteria reproduction), 202 (daphnid acute), 211 (daphnid 251 reproduction), 222 (earthworm reproduction), 225 (sediment lumbriculus assay), 315 (sediment oligochaete 252 bioaccumulation) and 317 (terrestrial oligochaete bioaccumulation) were generally applicable to 253 nanomaterials. However, some of them may need adaptation (e.g. to avoid possible nanomaterial 254 interference with biomass quantification in TG 201). In addition, new environmental TGs, and new GDs for 255 ecotoxicity and fate testing were proposed that address some of the adaptations needed: Table 7 and 8 give 256 an overview. The ecotoxicity and fate GDs will rely in part on two proposed new fate TGs: a TG on 257 agglomeration behaviour of nanomaterials in different aquatic media; and a TG for dissolution rate of 258 nanomaterials in the aquatic environment. 259 The test for bioconcentration of traditional chemicals in fish (TG 305) is not appropriate for nanomaterials 260 due to the partitioning of most nanomaterials in environmental media; and a new GD needs to be developed 261 (Table 7). Two test guidelines, TG 105, water solubility, and TG 106, adsorption-desorption, were not 262 recommended for nanomaterials. It was proposed that a new nano-specific test guideline or an update of TG 263 106 on adsorption/desorption on soils be developed (Table 8). As nanomaterials do not sorb to sludge 264 according to the same equilibrium kinetics that apply to traditional chemicals, TG 303A “Aerobic Sewage 265 Treatment Simulation Test” is expected to be inadequate for nanomaterials as is the U.S. EPA OPPTS 266\nM AN\nUS CR\nIP T\nAC\nCE\nPT\nED\nACCEPTED MANUSCRIPT\n835.1110 “Activated Sludge Sorption Isotherm”, but simple adjustments to this protocol may provide the 267 needed data (Westerhoff et al. 2011, Kiser et al. 2009). While the TG 303A protocol could be used for 268 determining nanomaterial removal during wastewater treatment, the TG 303A guideline is focused on 269 biodegradation processes which may not be applicable to most classes of nanomaterials. Determination of 270 sorption is critical to assessing amounts of nanomaterials released to surface waters, and to soils and 271 sediments (Kiser et al. 2009, Kiser et al. 2010, Kiser et al. 2012, Pan and Xing 2008). Other guidelines that 272 might need additional guidance are TG 312 on leaching from soils and TGs 315 and 317 on sediment 273 accumulation. 274\nThere is a need to determine a standardized protocol for predicting dissolution rates relevant for predicting 275 the bioavailability, reactivity, toxicity, and fate of nanomaterials such as metals, and a proposed new TG aims 276 to develop a protocol to determine agglomeration behaviour of nanomaterials in different aquatic media 277 that vary by media type, natural organic matter concentration, degree of agitation, etc. and provide data on 278 dispersion stability. The proposal for a GD on Aquatic (and Sediment) Toxicology Testing of Nanomaterials 279 recognizes that current toxicity guidelines may need adjustments when applied to particulate and colloidal 280 nanomaterials and will address the need to adequately produce and characterize test media containing 281 nanomaterials both for generation of stock media and exposure media, and provide guidance on data 282 analysis and reporting, with considerations for dosimetry, etc. 283\nTable 7. Test guidelines and guidance document proposals from the WPMN to the OECD Test Guidelines 284 Programme 285 286\nTitle Lead\nCountry(ies)\nIncluded in the OECD TGP work plan Expected timing of adoption by the OECD WNT\nAmendments to the Inhalation Test Guidelines and Guidance Document to Accommodate Nanomaterials\nUnited States April 2014 2016\nTest Guideline for Nanomaterial Removal from Wastewater\nUnited States April 2014 April 2015\nGuidance Document on Aquatic (and Sediment) Toxicology Testing of Nanomaterials\nCanada / United States /\nUnited Kingdom April 2014 2016\nTest Guideline on agglomeration behaviour of nanomaterials in different aquatic media\nGermany April 2014 2016\nGuidance Document (Decision-Tree) on agglomeration and dissolution behaviour of nanomaterials in aquatic media\nGermany April 2014 2016\nTest Guideline for dissolution rate of nanomaterials in United States April 2014 2016\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nthe aquatic environment Guidance Document on Assessing the Apparent Accumulation Potential of Nanomaterial for Test Guideline 305\nUnited Kingdom / Finland / Spain April 2014 2016\nGuidance Document on the Adaptation of in vitro Mammalian Cell Based Genotoxicity Test Guidelines for Testing of Manufactured Nanomaterials\nEuropean Commission April 2015 2017\n287 288\nTable 8. Test guidelines identified by the WPMN as relevant to revise or develop a guidance document for or a 289 new test guideline; currently no lead country is available. 290 291\nTitle of test guideline / guidance document to be revised or developed\nRevision of OECD TG 201 Algal Toxicity Revision / GD development for OECD TG 312 Soil Column Leaching New Test Guideline on Transformation of NMs GD for Spiking of Soils and Sediments, OECD TG 315 and 317 Revision of TG 105 (Water solubility) to reflect that it is not applicable to nanomaterials Update TG 106 (Adsorption / desorption) or develop new TG New Test Guideline or Guidance Document on determination of aggregation/agglomeration status of NMs New Test Guideline on determination of Zeta potential New Test Guideline or Guidance Document on particle size and size distribution or update of the existing guidance. New Test Guideline or Guidance Document on surface area (BET, metal oxides) Review document describing what techniques/methods are available for measuring surface chemistry along with appropriate caveats, e.g. which classes of nanomaterials are appropriate for the methods. Update or add appendices to the Guidance Document on Sample Preparation and Dosimetry\n292 A group of experts on inhalation toxicology provided a proposal to the WNT to amend the inhalation toxicity 293 test guidelines and guidance documents for nanomaterials. Recommendations for high priority changes 294 included the lowering of the upper cut-off of the size range for materials to be tested, the measurement of 295 lung burdens where feasible, the addition of specific post-dosing observation periods, and the recording of 296 specific bronchoalveolar lavage parameters. Other recommendations for incorporation into guidance 297 included the evaluation of additional lung biomarkers, gathering of additional biokinetics data, and 298 evaluation of effects on distal organs beyond the lungs. These amendments are driven by the need to assess 299 effects of nanomaterials as a result of deposition and retention in the deep lung. As seen from Table 7, the 300\nM\nAN\nUS\nCR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nOECD test guidelines programme has agreed to revise the test guidelines for Inhalation Toxicity, and a 301 related guidance document which takes into account nanomaterial aspects. 302\nAs for genotoxicity testing, the in vitro and in vivo micronucleus assays, the in vitro mammalian gene 303 mutation assays, and the in vitro and in vivo Comet assays are promising candidates to be adapted to enable 304 hazard identification of nanomaterials within the next few years (Gonzalez et al. 2011, Doak et al. 2012, 305 Pfuhler et al. 2013). In contrast to the genotoxicity testing of soluble chemicals, the type of dispersions of 306 particles and fibres as test items may determine the uptake of particulate material, including agglomerates, 307 in vitro and in vivo by the test organisms. Thus, a thorough quantitation of deposited dose on and into cells 308 in vitro and of organ dose in vivo may result in more accurate dose response relationships needed for hazard 309 characterisation (DeLoid et al. 2014, Hinderliter et al. 2010, Cohen et al. 2014). Consequently, false negative 310 results will be less likely. 311\nTable 9. Needed developments for genotoxicity testing of nanomaterials: Test guidelines, guidance documents or 312 other documents identified by the WPMN. 313\nTitle of test guideline / guidance document to be revised or developed Development of reporting requirements for manufactured nanomaterials genotoxicity TGs: Characterization of manufactured nanomaterials in as-produced state, and in test media Guidance on Toxicokinetic investigations needed prior to in vivo studies to determine if target tissues are exposed and cellular uptake. Modifications of TG 473 Chromosomal Aberration Test to accommodate manufactured nanomaterials Modifications of TG 487 (In vitro Micronucleus Test to accommodate manufactured nanomaterials) Review of generic well established modifications for Genotoxicity TGs for accommodating manufactured nanomaterials\n314 Recently it has been repeatedly shown that potential incorporation of nanomaterials and adverse cellular 315 effects are dependent on particle dose, size and intracellular solubility (Gliga et al. 2014, Semisch et al. 2014, 316 Shang et al. 2014, Tavares et al. 2014). Hence when testing the hazard potential of nanomaterials in the 317 future, the investigation of kinetic processes in vitro and in vivo toxicity testing clearly needs to be addressed 318 in more depth. 319\nFor the dermal exposure route, concerns were raised regarding the adequacy of the test guidelines on 320 dermal absorption TGs 427 and 428, especially relating to the observation time points. 321\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nOECD TG 417 on Toxicokinetics was found inappropriate for assessing the organ distribution of inhaled 322 nanomaterials as it was designed primarily for the oral exposure route and for traditional chemicals whose 323 kinetics are mainly governed by diffusion/perfusion and metabolic processes rather than for particulate 324 nanomaterials whose behaviour in terms of absorption, distribution and elimination (ADE) in the test 325 organisms may be fundamentally different. 326\nThe development of a new TG specifically tailored for the inhalation route, including adequate consideration 327 attention to the possible ADE particularities of nanomaterials was recommended. Currently, it is proposed to 328 amend the test guidelines for short term, acute, subchronic and chronic inhalation toxicity testing with 329 appropriate procedures for sample preparation (Creutzenberg 2012; OECD 2012b). The integration of 330 extended post observation periods in inhalation toxicity testing combined with organ burden investigations 331 (Krystek et al. 2014) may facilitate the estimation of elimination half-lives of nanomaterials and may help to 332 decide whether the nanoscale test item is persistent and potentially bioaccumulative in the body (Geraets et 333 al. 2014). Upon inhalation, low levels of primary nanoparticles have been shown to become systemically 334 available depending on size, shape, specific surface area, and de-agglomeration potential in the lung 335 (Balasubramanian et al. 2013, Mercer et al., 2013; Moreno-Horn and Gebel, 2014). 336\nAs a last step, the WPMN has looked into how results of testing and other information generating means 337 could be integrated in relevant testing strategies and assessment approaches based on grouping and read 338 across principles to optimise the use of information and minimise the need of testing (in particular in vivo); 339 this work is still on-going. 340\nAt the beginning of its work the WPMN performed a review of the applicability of the OECD test guidelines 341 to nanomaterials resulting in the publication of The WPMN the Preliminary Review of OECD Test Guidelines 342 for their Applicability to Manufactured Nanomaterials (OECD, 2009). The outcomes of the WPMN work 343 illustrated that for the end-points investigated, the OECD test guidelines can to a large extent be applied to 344 nanomaterials, however, a number of the TGs are being optimised and adapted for nanomaterials, and 345 Tables 7, 8 and 9 present an overview of work under way. The collaboration between WPMN and the OECD 346 test guidelines programmes will allow continued modification/development of new OECD test guidelines and 347 guidance documents specifically for nanomaterials. 348\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\n349 6. Discussion and Conclusions 350\nAs the WPMN Programme was designed nine years ago, the information that it initially set out to collect and 351 the questions that it hoped to answer have also developed with time. In parallel with the WPMN Testing and 352 Assessment Programme, additional nanomaterial related research results from academia and industry have 353 been made available in the scientific literature, and the understanding of nanomaterials is maturing. In 354 addition, the sponsors organised the actual testing by setting up national and international research 355 projects, thus promoting a global research effort, however making the feed-back to the WPMN 356 cumbersome, as for example intellectual property rights had to be safeguarded. 357\nIn 2013, based on outcomes of the WPMN testing programme and the parallel advances in scientific 358 understanding of nanomaterials outside the WPMN, the OECD and its member countries came to the 359 conclusion that the approaches for the testing and assessment of traditional chemicals are in general 360 appropriate for assessing the safety of nanomaterials (OECD 2009b), but may have to be adapted to the 361 specificities of nanomaterials. This was endorsed by the OECD Council through a Recommendation (OECD 362 2013a). OECD Council Decisions (on the Mutual Acceptance of Data) are legally binding on OECD member 363 countries, the European Commission and those other non-OECD countries which have adhered to them 364 (there are currently six). In essence, this system means that data collected as part of a regulatory risk 365 assessment of a chemical in one country must be (in a legal sense) accepted in all countries. This avoids 366 undertaking the same test many times over and quantifiable evidence has been published on the savings this 367 makes for governments and industry. The two provisos to this system are that an agreed OECD Test 368 Guideline or Guidelines have been used and the OECD Principles of Good Laboratory Practice have been 369 applied during the collection of the data. The significance of the OECD nano recommendation is that it aligns 370 nanomaterials (as chemical substances) with the legally-binding system of Mutual Acceptance of Data, 371 having a global impact on regulatory management of nanomaterials, and it also opens the avenue to 372 providing additional global regulatory agreements on nano-relevant guidance for regulatory testing of 373 nanomaterials. The majority of test guidelines are suitable already for nanomaterials and the Mutual 374 Acceptance of Data applies. A small number of endpoints necessitates new nano specific test guidelines or 375\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nguidance, and work on new test guidelines or guidance is well underway as indicated for example in Tables 7 376 and 8. 377\nThus, as with other chemical substances, it is clear that each nanomaterial may pose specific challenges, but 378 in most instances, they can be addressed with existing test methods and assessment approaches. In some 379 cases, it might be necessary to adapt methods of sample preparation and dosimetry for safety testing. Many 380 of the adaptations identified thus far have been triggered by the insoluble or partially soluble nature of many 381 nanomaterials. One area that needs further development is the area of physical-chemical property 382 estimation, both in silico and testing, since some of the endpoints considered to be relevant for 383 nanomaterials differ from those typically considered for traditional chemicals. 384\nDepending on the dispersion protocols used, different results may be obtained for the end-point examined, 385 as it is well established that particle toxicity is not only determined by a particle's chemical composition but 386 also by its interaction with the biological entourage. Biophysical characterisation may therefore be required 387 in support of understanding of test items. 388\nThe work program is being fulfilled and has already generated both data (results from the testing) and 389 actions (guidance provided, work initiated on TGs and other guidance documents, and additional proposals 390 on the table waiting for concurrence). The complete evaluation and extraction of conclusions continues, and 391 interested parties should contact the WPMN Secretariat (peter.kearns@oecd.org mar.gonzalez@oecd.org), 392 or work through their member country or organizational representatives to the OECD. 393\nAcknowledgement: The authors are grateful to Dr M.E. Goetz from the Federal Institute of Risk Assessment 394 in Germany for his comments to earlier versions of this article, and to Mr S. Haastrup from the Technical 395 University of Denmark for text review. Also, the authors wish to convey a heartfelt thanks to the delegates to 396 the OECD WPMN meetings, the contributors to the Testing Programme and the participants to the expert 397 meetings for sharing information, scientific in-sights and active discussions, which have all contributed to the 398 overview information presented here, and without which the present work would have been impossible. 399\n400\nDisclaimer 401\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nThe views stated in this paper are purely those of the authors and do not necessarily represent the opinions 402 of their respective employers. 403\n404\nConflict of interest 405\nThe authors have no conflict of interest to report. 406\n407\n7. References2 408\nBalasubramanian et al. 2013. Balasubramanian S.K., Poh K.-W., Ong C.N., Kreyling W.G., Ong W.Y., Yu, L.E. 409 “The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates.” Biomaterials, 410 2013, 34, 5439-5452. 411\nCalzolai et al. 2011. Calzolai L., Gilliland D., Garcia C.P. and Rossi F. (2011) Separation and characterization of 412 gold nanoparticle mixtures by flow-field-flow fractionation. Journal of Chromatography A,1218 (27), pp. 413 4234-4239 414\nCohen et al. 2014. Cohen J.M., Teeguarden J.G., Demokritou P. ”An integrated approach for the in vitro 415 dosimetry of engineered nanomaterials.” Particle and Fibre Toxicology, 11:20 2014. 416\nCreutzenberg 2012. Creutzenberg O. “Biological interactions and toxicity of nanomaterials in the respiratory 417 tract and various approaches of aerosol generation for toxicity testing.” Archives of Toxicology, 2012, 86, 418 pp.1117-1122. 419\nDeLoid et al. 2014. DeLoid G., Cohen, J.M., Darrah T., Derk R., Rojanasakul L., Pyrgiotakis G., Wohlleben W., 420 Demokritou P., “Estimating the effective density of engineered nanomaterials for in vitro dosimetry.” Nature 421 Communications, 2014, 5:3514 422\nde Temmerman et al. 2012. de Temmerman P.-J., van Doren E., Verleysen E., van der Stede Y., Francisco 423 M.A.D. and Mast J. “Quantitative characterization of agglomerates and aggregates of pyrogenic and 424\n2 All links to URLs in the list of references were accessed 28 May 2015\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nprecipitated amorphous silica nanomaterials by transmission electron microscopy.” Journal of 425 Nanobiotechnology 2012, 10:24 426\nDoak et al. 2012. Doak S.H., Manshian B., Jenkins G.J.S., Singh J.N. “In vitro genotoxicity testing strategy for 427 nanomaterials and the adaptation of current OECD guidelines.” Mutation Research/Genetic Toxicology and 428 Environmental Mutagenesis, 2012, 745 pp. 104-111. 429\nEuropean Commission, 2012. Commission Staff Working Paper. SWD(2012) 288 final of 3.10.2012. Types 430 and uses of nanomaterials, including safety aspects, accompanying the Communication from the 431 Commission to the European Parliament, the Council and the European Economic and Social Committee on 432 the Second Regulatory Review on Nanomaterials. 433\nGeraets et al. 2014. Geraets L., Oomen A.G., Krystek P., Jacobsen N.R., Wallin H., Laurentie M., Verharen 434 H.W., Brandon E.F.A., de Jong W.H. “Tissue distribution and elimination after oral and intravenous 435 administration of different titanium dioxide nanoparticles in rats.” Particle and Fibre Toxicology, 2014, 11:30. 436\nGliga et al. 2014. Gliga A.R., Skoglund S., Wallinder I.O., Fadeel B., Karlsson H.L. ”Size-dpendent cytotoxicity 437 of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release.” 438 Particle and Fibre Toxicology, 2014, 11:11. 439\nGonzalez et al. 2011. Gonzalez L., Sanderson B.J.S., Kirsch-Volders M. “Adaptations of the in vitro 440 micronucleus assay for the genotoxicity assessment of nanomaterials.” Mutagenesis, 2011, 26:1, pp. 185-441 191. 442\nHartmann et al. 2015. Hartmann N.B., Jensen K. A., Baun A., Rasmussen K., Rauscher H., Tantra R., Cupi D., 443 Gilliland D., Pianella F., Riego Sintes J.M. \"Techniques and Protocols for Dispersing Nanoparticle Powders in 444 Aqueous Media – is there a Rationale for Harmonization?\" Journal of Toxicology and Environmental Health, 445 Part B. 00:1-28. 2015. 446\nHinderliter et al. 2010. Hinderliter P.M., Minard K.R., Orr G., Chrisler W.B., Thrall B.D., Pounds J.G., 447 Teeguarden J.G., ”ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry 448 for in vitro toxicity studies.” Particle and Fibre Toxicology, 2010, 7:36 449\nJacobsen et al. 2010. Jacobsen N.R., Pojano G., Wallin H., Jensen K.A. 2010. Nanomaterial dispersion 450\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nprotocol for toxicological studies in ENPRA. Internal ENPRA Project Report. NRCWE 6: Internal ENPRA report 451 pp. 1–10. 452 Kiser et al. 2009. Kiser M.A., Westerhoff P., Benn T., Wang Y., Perez-Rivera J., Hristovski, K. \"Titanium 453 nanomaterial removal and release from wastewater treatment plants\". Environ. Sci. Technol. 2009. 43:6757-454 6763. 455\nKiser et al. 2010. Kiser M.A.; Ryu J.; Jang H.; Hristovski K.; Westerhoff P.K. Biosorption of nanoparticles to 456 heterotrophic wastewater biomass. Wat. Res. 2010, 44 (14), 4105-4114 457\nKiser et al. 2012. Kiser M.A.; Ladner D.A.; Hristovski K.D.; Westerhoff P.K. Nanomaterial transformation and 458 association with fresh and freeze-dried wastewater activated sludge: Implications for testing protocol and 459 environmental fate. Env. Sci. & Tech. 2012, 46 (13), 7046-7053. 460\nKrystek et al. 2014. Krystek P. Tentschert J., Nia Y., Trouiller B., Noël L., Goetz M.E., Papin A., Luch., Guérin 461 T., de Jong W. Method development and inter-laboratory comparison about the determination of titanium 462 from titanium dioxide nanoparticles in tissues by inductively coupled plasma mass spectrometry.” Anal. 463 Bioanal. Chem. 2014 Jun;406(16):3853-61. 464\nKühnel and Nickel 2014. Kühnel D. and Nickel C. The OECD expert meeting on ecotoxicology and 465 environmental fate - Towards the development of improved OECD guidelines for the testing of 466 nanomaterials. Science of the total environment. Volume 472, 15 February 2014, Pages 347-353 467\nMercer et al. 2013. Mercer R.R., Scabilloni J.F., Hubbs A.F., Wang L., Battelli L.A., McKinney W., Castranova V. 468 and Porter D.W. \"Extrapulmonary transport of MWCNT following inhalation exposure.\" Particle and Fibre 469 Toxicology 10:38. 2013. 470\nMoreno-Horn and Gebel 2014. Moreno-Horn M. and Gebel T. “Granular biodurable nanomaterials: No 471 convincing evidence for systemic toxicity.” Critical Reviews in Toxicology Nov. 2014, Vol. 44, No. 10:849–875. 472\nMorris et al. 2011. Morris J., Willis J., De Martinis D., Hansen B., Laursen H., Riego Sintes J., Kearns P., 473 Gonzalez M. Science policy considerations for responsible nanotechnology decisions\". Nature 474 Nanotechnology vol. 6, 73 (2011) 475\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nNel et al. 2013. Nel A., Xia T., Meng H., Wang X., Lin S. Ji., Zhang H. (2013) Nanomaterial toxicity testing in 476 the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc. Chem. 477 Res. Mar. 19; 46(3):607-21 478\nOECD 1981. OECD. Decision of the Council concerning the Mutual Acceptance of Data in the Assessment of 479 Chemicals. 12 May 1981 - C(81)30/FINAL 480\nOECD 2009a. Guidance Manual for the Tetsting of Manufactured Nanomaterials: OECD’s Sponsorship 481 programme; first revision. ENV/JM/MONO(2009)20/REV Available at URL: 482 http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono%282009%2920/re483 v&doclanguage=en 484\nOECD 2009b. OECD. Preliminary Review of OECD Test Guidelines for their Applicability to Manufactured 485 Nanomaterials (2009). ENV/JM/MONO(2009)21. Available at URL: 486 http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?doclanguage=en&cote=env/jm/mono(487 2009)21 488\nOECD 2012a. OECD. Inhalation Toxicity Testing: Expert Meeting on Potential Revisions to OECD Test 489 Guidelines and Guidance Document (2012). ENV/JM/MONO(2012)14. Available at URL: 490 http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2012)14&doclang491 uage=en 492\nOECD 2012b. OECD. Guidance on Sample Preparation and Dosimetry for the Safety testing of Manufactured 493 Nanomaterials. ENV/JM/MONO(2012)40 494\nOECD 2012c. OECD. Nanosafety at the OECD. The first six years. 2012. Available at 495 URL:http://www.oecd.org/env/ehs/nanosafety/Nano%20Brochure%20Sept%202012%20for%20Website%20496 %20(2).pdf 497\nOECD 2013a. OECD. Recommendation of the Council on the Safety Testing and Assessment of Manufactured 498 Nanomaterials. OECD. 19 September 2013 – C(2013)107. 499\nOECD 2013b. OECD. Co-operation on Risk Assessment: Prioritisation of Important Issues on Risk Assessment 500 of Manufactured Nanomaterials – Final Report. ENV/JM/MONO(2013)18. OECD, Paris. 2013. Available at 501\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nURL:http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2013)18&docl502 anguage=en 503\nOECD 2014a. Report of the OECD Expert Meeting on the Physical Chemical Properties of Manufactured 504 Nanomaterials and Test Guidelines. ENV/JM/MONO(2014)15. Available at URL: http://www.oecd.org/ 505 officialdocuments/publicdisplaydocumentpdf/?cote=ENV/JM/MONO(2014)15&docLanguage=En 506\nOECD 2014b. Ecotoxicology and Environmental Fate of Manufactured Nanomaterials: Test Guidelines. 2014. 507 ENV/JM/MONO(2014)1. Available at URL: http://www.oecd.org/officialdocuments/ 508 publicdisplaydocumentpdf/?cote=ENV/JM/MONO(2014)1&doclanguage=en 509\nOECD 2014c. Genotoxicity of Manufactured Nanomaterials: Report of the OECD Expert Meeting. 2014. 510 ENV/JM/MONO(2014)34. Available at URL: 511 http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2014)34&doclang512 uage=en 513\nPan and Xing, 2008. Pan B. and Xing B. Adsorption Mechanisms of Organic Chemicals on Carbon Nanotubes 514 Environ. Sci. Technol. no. 42 (24):9005-9013. 2008 515\nPfuhler et al. 2013. Pfuhler S., Elespuru R., Aardema M.J., Doak S.H., Donner E.M., Honma M., Kirsch-Volders 516 M., Landsiedel R., Manjanatha M., Singer T., Kim J.H., “Genotoxicity of nanomaterials: Refining strategies and 517 tests for hazard identification.” Environmental and Molecular Mutagenesis, 2013, 54, pp. 229-239. 518\nRasmussen et al. 2013. Rasmussen K., Mech A., Mast J., de Temmerman P.-J., Waegeneers N., Van Steen F., 519 Pizzolon J. C., de Temmerman L., Van Doren E., Jensen K.A., Birkedal R., Levin M., Nielsen S.H., Koponen I.K., 520 Clausen P.A., Kembouche Y., Thieriet N., Spalla O., Guiot C., Rousset D., Witschger O., Bau S., Bianchi B., 521 Shivachev B., Gilliland D., Pianella F., Ceccone G., Cotogno G., Rauscher H., Gibson N. and Stamm H. 522 \"Synthetic Amorphous Silicon Dioxide (NM-200, NM-201, NM-202, NM-203, NM-204): Characterisation and 523 Physico-Chemical Properties\". European Commission. EUR 26046 EN. 2013 524\nSCENIHR 2006. The appropriateness of existing methodologies to assess the potential risks associated with 525 engineered and adventitious products of nanotechnologies. 2006. Available from URL: 526 http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_003b.pdf 527\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nSCENIHR 2007a. Opinion on the appropriateness of the risk assessment methodology in accordance with the 528 technical guidance documents for new and existing substances for assessing the risks of nanomaterials. 529 2007. Available from URL: 530 http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_010.pdf 531\nSCENIHR 2007b. Opinion on the scientific aspects of the existing and proposed definitions relating to 532 products of nanoscience and nanotechnologies. 2007. Available at URL: 533 http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_012.pdf 534\nSCENIHR 2009. Risk Assessment of Products of Nanotechnologies. 2009. Available at URL: 535 http://ec.europa.eu/health/archive/ph_risk/committees/04_scenihr/docs/scenihr_o_023.pdf 536\nShang et al. 2014. Shang L., Nienhaus K., Nienhaus G.U. “Engineered nanoparticles interacting with cells: size 537 matters.” Journal of Nanobiotechnology, 12:5, 2014 538\nSemisch et al. 2014. Semisch A., Ohle J., Witt B., Hartwig A. „Cytotoxicity and genotoxicity of nano- and 539 microparticulate copper oxide: role of solubility and intracellular bioavailability.“ Particle and Fibre 540 Toxicology, 2014, 11:10. 541\nSingh et al. 2013. Singh C., Friedrichs S., Levin M., Birkedal R., Jensen K.A., Pojana G., Wohlleben W., Schulte 542 S., Wiench K., Turney T., Koulaeva O., Marshall D., Hund-Rinke K., Kördel W., Van Doren E., De Temmerman 543 P-J., Abi Daoud Francisco M., Mast J., Gibson N., Koeber R., Linsinger T., Klein C.L.. \"NM-Series of 544 Representative Manufactured Nanomaterials - Zinc Oxide NM-110, NM-111, NM-112, NM-113: 545 Characterisation and Test Item Preparation\". European Commission. EUR 25066. 2013 546\nSingh et al. 2014. Singh C., Friedrichs S., Ceccone G., Gibson N., Jensen K.A., Levin M., Goenaga Infante H., 547 Carlander D. and Rasmussen K. \"Cerium Dioxide NM-211, NM-212, NM-213. Characterisation and test item 548 preparation. NM-Series of Representative Manufactured Nanomaterials\". European Commission. EUR 549 26649. 2014 550\nTantra et al. 2014. Tantra R., Sikora A., Hartmann N.B., Riego Sintes J. and Robinson K.N. \"Comparison of the 551 effects of different protocols on the particle size distribution of TiO2 dispersions.\" Particuology, 19; 35-44 552 (2015) 553\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nTavares et al. 2014. Tavares A.M., Loura H., Antunes S., Quarré S., Simar S., de Temmerman P.-J., Verleysen 554 E., Mast J., Jensen K.A., Norppa H., Nesslany F., Silva M.J. “Genotoxicity evaluation of nanosized titanium 555 dioxide, synthetic amorphous silica and multi-walled carbon nanotubes in human lymphocytes.” Toxicology 556 in vitro, 2014, 28, pp. 60-69. 557\nTeeguarden et al. 2007. Teeguarden J. G., Hinderliter P. M., Orr G., Thrall B. D. and Pounds J. G. 558 \"Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity 559 assessments.\" Toxicological Sciences 2007 Feb: 95(2):300-12. 560\nWesterhoff et al. 2011. Westerhoff P., Song G., Hristovski K. and Kiser M.A. Occurrence and removal of 561 titanium at full scale wastewater treatment plants: Implications for TiO2 nanomaterials. 2011. J. Env. Monit, 562 12:1195-1203. 563\nM AN\nUS CR\nIP T\nAC CE\nPT ED\nACCEPTED MANUSCRIPT\nHIghlights\n• Overview the OECD Programme on Testing and Assessment of Manufactured Nanomaterials • Overview of 11 nanomaterials tested for physchem properties, (eco)toxicity and fate • Indications that many existing OECD test guidelines are suitable for nanomaterials • The legally binding Mutual Acceptance of Data covers nanomaterial data via OECD TGs • Overview of areas of development for new OECD test guidelines for nanomaterials"
    } ],
    "references" : [ ],
    "referenceMentions" : [ ],
    "year" : 2015,
    "abstractText" : "14 This paper charts the almost ten years of history of OECD’s work on nanosafety, during which the 15 programme of the OECD on the Testing and Assessment of Manufactured Nanomaterials covered 16 the testing of eleven nanomaterials for about 59 end-points addressing physical-chemical properties, 17 mammalian and environmental toxicity, environmental fate and material safety. An overview of the 18 materials tested, the test methods applied and the discussions regarding the applicability of the 19 OECD test guidelines, which are recognised methods for regulatory testing of chemicals, are given. 20 The results indicate that many existing OECD test guidelines are suitable for nanomaterials and 21 consequently, hazard data collected using such guidelines will fall under OECD’s system of Mutual 22 Acceptance of Data (MAD) which is a legally binding instrument to facilitate the international 23 acceptance of information for the regulatory safety assessment of chemicals. At the same time, 24 some OECD test guidelines and guidance documents need to be adapted to address nanomaterials 25 while new test guidelines and guidance documents may be needed to address endpoints that are 26 more relevant to nanomaterials. This paper presents examples of areas where test guidelines or 27 guidance for nanomaterials are under development. 28",
    "creator" : "Elsevier"
  }
}